Precipio, Inc. (PRPO)
$28.10-$0.75 (-2.60%) TodayExtended Hours
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 1,044 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
41 Form 4 filings on record, the earliest from Oct 17, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kathleen Laporte - Director | Grant or award | Common Stock | 2,232 | $5.60 | $12K | |
 David Seth Cohen - Director | Grant or award | Common Stock | 2,343 | $5.60 | $13K | |
| Ahmed Zaki Sabet - Officer | Open-market purchase | Common Stock | 79 | $6.00 | $474 | |
 Jeffrey Cossman - Director | Grant or award | Common Stock | 1,721 | $6.10 | $10K | |
| Richard A. Sandberg - Director | Open-market sale | Common Stock | 12,000 | $6.20 | $74K | |
| Richard A. Sandberg - Director | Open-market purchase | Common Stock | 15,000 | $5.80 | $87K | |
| Richard A. Sandberg - Director | Open-market sale | Common Stock | 2,000 | $6.28 | $13K | |
| Christina Rizopoulos Valauri - Director | Grant or award | Common Stock | 1,472 | $6.62 | $10K | |
| Jeffrey Cossman - Director | Grant or award | Common Stock | 1,586 | $6.62 | $10K | |
| Richard A. Sandberg - Director | Grant or award | Common Stock | 2,492 | $6.62 | $16K | |
| David Seth Cohen - Director | Grant or award | Common Stock | 1,982 | $6.62 | $13K | |
| Ronald Asbury Andrews - Director | Grant or award | Common Stock | 1,510 | $6.62 | $10K |
This is as far as the anonymous view goes. Create a free account for all 41 PRPO filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
Precipio, Inc. (PRPO) had 3 insider filings in the last 90 days, with the most recent on 2026-07-16. The full record for PRPO runs to 41 Form 4 filings, the earliest from 2024-10-17. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of PRPO were filed in the last 90 days. 13 purchases are on record for this company.
No insider sales of PRPO were filed in the last 90 days. 7 sales are on record for this company.
This page tracks PRPO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add PRPO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
$PRTAPROTHENA CORP PUBLIC LTD CO
$PRVAPrivia Health Group, Inc.
$PSNLPersonalis, Inc.
$PSTVPLUS THERAPEUTICS, INC.
$PTCTPTC THERAPEUTICS, INC.
$PTGXProtagonist Therapeutics, Inc
$PTHSPelthos Therapeutics Inc.
$PTNPALATIN TECHNOLOGIES INC
$PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
$PVLAPALVELLA THERAPEUTICS, INC.Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
